You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Hepato-pancreato-biliary (HPB) Cancers
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Appointment
Find a Condition or Treatment
Health Buddy App
Menu
MAIN
Back to Home
About Us
Corporate Profile
Newsroom
Visitors Information
Contact Us
New NCCS Building & Proton Therapy Centre
Patient Care
Cancer Information & Patient Support
E-Services
Specialties & Services
Your Clinic Visit
Find a Doctor
Research & Innovation
Research Labs
Programmes
Facilities
Our Researchers
Clinical Trials
SingHealth Research
Education & Training
Overview
Professional Development
Fellowship Programme
Events
Singhealth Academy
Careers
Sponsorship
Giving
Why Give
Get Involved
Your Gift at Work
Be Informed
Make a Gift
Our Campaign
Volunteer
Research Labs
Back to Home
Cellular & Molecular Research
Bek Chai Heah Laboratory of Cancer Genomics
Laboratory of Molecular Carcinogenesis
Laboratory of Molecular Endocrinology
Laboratory of Liver Cancer Functional Genomics
Laboratory of Cancer Signalling
Lymphoma Genomic Translational Research Laboratory
Laboratory of Molecular Oncology
Laboratory of Clinical Pharmacology
Medical Sciences
Laboratory of Cancer Epigenome
Cancer Therapeutics Research Laboratory
Laboratory of Cell Therapy and Cancer Vaccine
Tan Chin Tuan Lab of Optical Imaging and Photodynamic & Proton Therapy
Laboratory of Translational Research in Gastrointestinal Cancer
Laboratory of Genomic Medicine
Programme in Translational and Clinical Liver Research
Translational Cancer Biology Laboratory
Laboratory of Applied Human Genetics
Laboratory of Haematopoietic Stem Cells, Blood Cancers and Cellular Therapy
Clinical Trials & Epidemiological Sciences
Clinical Trials Office
Biostatistics & Epidemiology Unit
NCCS Research Committee & Scientific Advisory Board
Research Divisions Organisation Chart
Programmes
Back to Home
Disease Focus
Research Themes
Facilities
Back to Home
Overview
Specialised Units
Shared Facilities
Shared Services
Our Researchers
Back to Home
Division of Medical Oncology
Division of Surgery & Surgical Oncology, SGH and NCCS
Division of Radiation Oncology
Division of Oncologic Imaging
Division of Supportive and Palliative Care
Cellular and Molecular Research
Division of Medical Sciences
Clinical Trials & Epidemiological Sciences
Research Biennial Book
Clinical Trials
Back to Home
About Clinical Trials
Current Clinical Trials
ECRU
About Clinical Trials & Epidemiological Sciences
Clinical Trials Office
Biostatistics and Epidemiology Unit
SingHealth Research
Home
to skip to the main content on a page
to skip to the main content on a page
Home
>
Research & Innovation
>
Our Researchers
>
Hepato pancreato biliary (HPB) Cancers
Hepato-pancreato-biliary (HPB) Cancers
Facebook
WhatsApp
Email Us
share
Font Resize
A-
A
A+
Print
By:
Overview
Ongoing programs
Advanced Gastrointestinal and Sarcoma Surgical Oncology (AGISSO)
Breast Cancer
Hepato-pancreato-biliary (HPB) Cancers
Thoracic Surgery
Publications
Page Content
DSO hosts the multi-disciplinary Comprehensive Liver Cancer Clinic (CLCC) at NCCS comprising HPB surgeons, medical oncologists, radiation oncologist, nuclear medicine physicians, interventional radiologists, oncologic diagnostic radiologists, pathologists and nurse practitioners. The CLCC manages the whole spectrum of patients with HPB malignancies and multi-disciplinary case discussions are conducted twice a week. The HPB surgery team is heavily involved in clinically-driven cutting-edge translational and clinical studies that aim to interrogate the molecular and mechanistic basis of liver cancer, improve patient diagnosis and prognosis and develop novel therapies for HPB diseases by bringing discoveries from the bench to the bedside that can be translated to the next effective therapy.
The HPB discipline has vast experiences in conducting multicentre clinical trials and has spearheaded numerous investigator-initiated multicentre HCC clinical trials leveraging on the Asia-Pacific Hepatocellular Carcinoma (AHCC) trials group which has over 40 sites in 17 different countries and has completed 6 multi-centre prospective studies.
The team also coordinates the NMRC Flagship Translational and Clinical Research Program in Liver Cancer. The program conducts the world’s first prospective multi-center clinico-omics (genomics, immunomics, metabolomics) HCC study with PDX and PDP components. This prospective study is carried out in collaboration with major research institutes in Singapore (NUS/CSI, IMCB, CIS, NTU) and internationally.
10/10/2018 5:16 PM
×
SUBSCRIBE VIA EMAIL
Subscribe to our mailing list to get the updates to your email inbox...
Find a Doctor
Condition & Treatment
Home
Appointment
E-services